Breaking News Instant updates and real-time market news.

HCLP

Hi-Crush Partners

$6.35

0.15 (2.42%)

, APRN

Blue Apron

$1.22

-0.03 (-2.40%)

08:45
11/14/18
11/14
08:45
11/14/18
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Hi Crush (HCLP) 46.27% +0.89, Blue Apron (APRN) 15.44% +0.29, Buckeye Partners (BPL) 0.48% +0.22, Endocyte (ECYT) 0.88% +0.22, iShares (AAXJ) 0.73% +0.17, EWZ (EWZ) 3.51% +0.17, Neptune Technologies (NEPT) 10.75% +0.09, Cronos Group (CRON) 64.93% +0.08, ProShares UltraPro Short Dow 30 (SDOW) 6.10% +0.07, and FAS (FAS) 0.74% +0.06.

HCLP

Hi-Crush Partners

$6.35

0.15 (2.42%)

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

BPL

Buckeye Partners

$31.66

-0.535 (-1.66%)

ECYT

Endocyte

$23.59

0.03 (0.13%)

AAXJ

iShares MSCI All Country Asia Ex Japan

$64.36

1.13 (1.79%)

EWZ

MSCI Brazil Index

$38.32

-0.6 (-1.54%)

NEPT

Neptune Wellness

$3.20

-0.14 (-4.19%)

CRON

Cronos Group

$8.29

-0.15 (-1.78%)

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

HCLP Hi-Crush Partners
$6.35

0.15 (2.42%)

10/17/18
JEFF
10/17/18
DOWNGRADE
Target $6
JEFF
Underperform
Hi-Crush Partners downgraded to Underperform from Hold at Jefferies
Jefferies analyst Bradley Handler downgraded Hi-Crush Partners to Underperform and lowered his price target for the shares to $6 from $12.
10/17/18
JEFF
10/17/18
DOWNGRADE
JEFF
Jefferies downgrades four names on 'sinking' white sand demand
Jefferies analyst Brad Handler downgraded Hi-Crush Partners (HCLP) and Smart Sand (SND) to Underperform from Hold as well as Covia (CVIA) and U.S. Silica (SLCA) to Hold from Buy citing "sinking" Northern white sand demand and prices. The analyst sees the weakness spreading to regional/in-basin sand and ultimately to box/silo-based last-mile solutions as "supply adds overtake demand growth." He also expects the Q3 earnings season to drive downward estimate revisions. Smart Sand, Covia and Hi-Crus have the highest Northern white sand exposure, Handler tells investors in a research note.
11/02/18
LEHM
11/02/18
DOWNGRADE
Target $5
LEHM
Underweight
Hi-Crush Partners downgraded to Underweight from Equal Weight at Barclays
Barclays analyst J David Anderson downgraded Hi-Crush Partners to Underweight and lowered his price target for the shares to $5 from $13. The analyst reduced his EBITDA estimates following the Q3 results to reflect lower volumes and declining pricing. He also sees less support for the distribution.
10/05/18
UBSW
10/05/18
DOWNGRADE
Target $10
UBSW
Neutral
Hi-Crush Partners downgraded to Neutral from Buy at UBS
UBS analyst Sasha Sanwal downgraded Hi-Crush Partners to Neutral and lowered his price target for the shares to $10 from $18. The analyst cites distribution risk and industry headwinds for the downgrade.
APRN Blue Apron
$1.22

-0.03 (-2.40%)

10/05/18
KEYB
10/05/18
NO CHANGE
KEYB
Sector Weight
Blue Apron deal with GrubHub and one-time test provide flexibility, says KeyBanc
KeyBanc analyst Edward Yruma believes Blue Apron's (APRN) new partnership with GrubHub (GRUB) should provide a solid foundation for the launch of its on-demand meal kit offering and that its beta-test of its one-time delivery option on its own platform provides increased flexibility for customers. The analyst, who see the one-time delivery option as a unique offering, keeps a Sector Weight rating on Blue Apron shares.
08/03/18
ADAM
08/03/18
NO CHANGE
Target $6
ADAM
Buy
Blue Apron downside risk limited at current levels, says Canaccord
Canaccord analyst Michael Graham noted Blue Apron reported mixed Q2 results and said the guidance suggests the revenue impact from the "transition" year will get worse in Q3 and Q4 before it gets better. Despite that, he sees reasons to be optimistic heading into 2019, including a likely return to intensive marketing and upside from nascent multi-channel offerings. Graham maintained his Buy rating and lowered his price target to $6 from $8 on Blue Apron shares.
07/13/18
KEYB
07/13/18
NO CHANGE
KEYB
Sector Weight
Blue Apron's Costco test 'progressign well,' says KeyBanc
KeyBanc analyst Edward Yruma told investors in a research note that Blue Apron's (APRN) expansion of its on-demand meal kits at Costco (COST) continues to progress well, spreading to the Midwest and Southern areas of the U.S., and that this reinforces his increasingly constructive stance. While still small compared to direct-to-consumer, Yruma says the kits provide an opportunity for Blue Apron to conveniently reach new customers with a best-in-class national partner and that its upside prospects are becoming more favorable. Yruma maintains a Sector Weight rating, says valuation looks reasonable, and adds that operational issues at the Linden fulfillment centers are "largely in the past."
02/16/18
02/16/18
UPGRADE

Neutral
Blue Apron upgraded to Neutral on retail partnership potential at Northcoast
As previously reported, Northcoast analyst Charles Cerankosky upgraded Blue Apron to Neutral from Sell. He noted that management is suggesting the company could be at breakeven EBITDA by year end, though he "is far less optimistic." Still, given the pressure of its negative cash flow, he thinks Blue Apron will explore a retail distribution partnership, which could have a potential headline benefit. However, Cerankosky added that he expects that even if such a retail distribution partnership was struck, he believes "disappointing sales at retail would likely force such a relationship to die quickly."
BPL Buckeye Partners
$31.66

-0.535 (-1.66%)

10/10/18
FBCO
10/10/18
INITIATION
Target $35
FBCO
Neutral
Buckeye Partners initiated with a Neutral at Credit Suisse
Credit Suisse analyst Spiro Dounis initiated Buckeye Partners with a Neutral rating and a price target of $35.
07/23/18
07/23/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Papa John's (PZZA) downgraded to Sell from Hold at Stifel with analyst Chris O'Cull saying the outlook for Papa John's is "growing dimmer" after recent media reports indicated a "fraternal corporate culture." 2. Buckeye Partners (BPL) downgraded to Sell from Hold at SunTrust with analyst Tristan Richardson saying the latest negative action by Moody's was "quicker than expected" and may lead to a cut in the company's distribution. 3. Walgreens Boots Alliance (WBA) downgraded to Market Perform from Outperform at Cowen with analyst Charles Ryhee saying he views it as poorly positioned in the move toward value-based care and believes the ownership of, rather than a partnership with, an insurance company is necessary to realize the benefits of cost trend improvements. 4. General Electric (GE) downgraded to Hold from Buy at Argus with analyst John Eade saying that despite his expectations of a turnaround, Q2 results were a "step in the opposite direction" suggesting the company will struggle to meet its FY18 guidance. 5. Philip Morris (PM) downgraded to Hold from Buy at Societe Generale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/18
RHCO
11/02/18
UPGRADE
RHCO
Hold
Buckeye Partners upgraded to Hold from Sell at SunTrust
11/02/18
11/02/18
UPGRADE
Target $36

Hold
SunTrust ups Buckeye Partners to Hold after distribution cut, divestiture plans
As previously reported, SunTrust analyst Tristan Richardson upgraded Buckeye Partners to Hold from Sell, stating that the company's 41% distribution cut and planned divestitures are a "substantial and an unequivocal action that ceases value destruction" and puts Buckeye on a path to quickly de-lever. Richardson raised his price target on Buckeye Partners shares to $36 from $31 despite reducing his 2019 and 2020 estimates by roughly $45M in each year to reflect the removal of the assets being sold.
ECYT Endocyte
$23.59

0.03 (0.13%)

10/18/18
WEDB
10/18/18
DOWNGRADE
WEDB
Neutral
Endocyte downgraded to Neutral from Outperform at Wedbush
Wedbush analyst David Nierengarten downgraded Endocyte (ECYT) to Neutral after the company agreed to be acquired by Novartis (NVS) for $24 per share. The analyst does not next another bidder to emerge.
10/19/18
WELS
10/19/18
DOWNGRADE
WELS
Market Perform
Endocyte downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough downgraded Endocyte (ECYT) to Market Perform from Outperform, citing the company's deal to be acquired by Novartis (NVS). He believes that the proposed acquisition price of $24 per share fairly reflects the potential value of the company's lead PSMA-targeted radionuclide therapeutic and sees Novartis as best positioned to realize that value based on its leadership in radionuclide therapeutics. Birchenough sees low odds of a competing offer and low risk of a material event to derail the acquisition, he added.
07/16/18
WEDB
07/16/18
NO CHANGE
Target $21
WEDB
Outperform
Endocyte price target raised to $21 from $15 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Endocyte to $21 from $15 as Xofigo safety concerns should strengthen 177Lu's competitive positioning. The analyst reiterates an Outperform rating on the shares.
04/13/18
JEFF
04/13/18
INITIATION
Target $17
JEFF
Buy
Endocyte initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft starts Endocyte with a Buy rating and $17 price target. The analyst believes the company's CAR-T program is "under-the-radar" and could have broad use in oncology.
AAXJ iShares MSCI All Country Asia Ex Japan
$64.36

1.13 (1.79%)

EWZ MSCI Brazil Index
$38.32

-0.6 (-1.54%)

NEPT Neptune Wellness
$3.20

-0.14 (-4.19%)

CRON Cronos Group
$8.29

-0.15 (-1.78%)

10/17/18
MSCO
10/17/18
NO CHANGE
MSCO
Morgan Stanley says pot legalization could pose risk to Canadian auto insurers
Morgan Stanley analyst Kai Pan noted that academic studies do not agree on the potential impact on car accidents from legalized recreational use of marijuana, but he still believes Canada's legalization could pose a risk to Canadian auto insurers. IFC, the largest auto insurer in Canada, is not immune to this challenge but given its long-term outperformance versus peers and strong claims management, Pan thinks the company should be better positioned in addressing this challenge, he tells investors. Publicly traded companies in the cannabis space include Aurora Cannabis (ACBFF), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
11/07/18
ADAM
11/07/18
NO CHANGE
ADAM
Midterms broadly positive for U.S. cannabis industry, says Canaccord
Canaccord analyst Bobby Burleson says that as expected, yesterday's midterms delivered several wins for the U.S. cannabis industry, including the passage of three state ballot measures on legalization, key gubernatorial victories by pro-cannabis candidates, and the retaking of the House by Democrats. The analyst views these results as broadly positive for the U.S. cannabis industry. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
10/12/18
VERI
10/12/18
INITIATION
VERI
Sell
Cronos Group initiated with a Sell at Veritas
Veritas analyst Stuart Rolfe started coverage of the Canadian Cannabis sector with four Sell ratings, including a Sell on Cronos Group, in a note entitled "End of the Rainbow." The analyst, who sees an intrinsic value of C$4.50 for Cronos shares, said that even assuming 60% of the black market converts, Canada's cannabis industry "looks wildly overvalued."
09/20/18
STFL
09/20/18
NO CHANGE
STFL
Top 22 Canadian cannabis stocks up 127% since Constellation pact, says Stifel
Yesterday's significant outperformance for Canadian cannabis stocks, led by Tilray (TLRY), at one point pushed the total market capitalization for Canadian Licensed Producers above $C80B, before they closed with a combined market cap of C$73B, calculates Stifel analyst Christopher Growe. Since August 15, when Constellation Brands (STZ) announced a pact to invest C$5B into Canopy Growth (CGC), the top 22 Canadian cannabis stocks are up 127% in stock price, noted Growe. A $C73B market cap in relation to what he estimates to be an addressable Canadian market of C$10B is "difficult to fathom," so valuations require global opportunities to be realized, added Growe, who said he questions the pace of development and degree of advantage for these companies. Companies in the cannabis space that can be traded in the U.S. include Aurora Cannabis (ACBFF), CV Sciences (CVSI), Canopy Growth, Cronos Group (CRON) and Tilray.

TODAY'S FREE FLY STORIES

SRAX

Social Reality

$3.39

-0.06 (-1.74%)

07:06
08/22/19
08/22
07:06
08/22/19
07:06
Hot Stocks
Social Reality changing name to SRAX August 26th »

SRAX will formally change…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLHF

Standard Lithium

$0.00

(0.00%)

07:05
08/22/19
08/22
07:05
08/22/19
07:05
Hot Stocks
Standard Lithium completes fabrication of Phase 1, 2 of 'LiSTR' plant »

Standard Lithium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLY

Fly Leasing

$18.25

0.265 (1.47%)

07:04
08/22/19
08/22
07:04
08/22/19
07:04
Hot Stocks
Fly Leasing CEO says 'FLY continues to achieve record results' »

"FLY continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 03

    Sep

  • 05

    Sep

WDAY

Workday

$190.87

4.53 (2.43%)

, CRM

Salesforce

$147.40

1.85 (1.27%)

07:04
08/22/19
08/22
07:04
08/22/19
07:04
Initiation
Workday, Salesforce initiated  »

Workday initiated with a…

WDAY

Workday

$190.87

4.53 (2.43%)

CRM

Salesforce

$147.40

1.85 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 12

    Dec

  • 16

    Dec

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:03
08/22/19
08/22
07:03
08/22/19
07:03
Hot Stocks
Breaking Hot Stocks news story on Clearside Biomedical »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

FLY

Fly Leasing

$18.25

0.265 (1.47%)

07:03
08/22/19
08/22
07:03
08/22/19
07:03
Hot Stocks
Breaking Hot Stocks news story on Fly Leasing »

Fly Leasing board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 03

    Sep

  • 05

    Sep

USNA

Usana

$67.47

0.43 (0.64%)

07:02
08/22/19
08/22
07:02
08/22/19
07:02
Initiation
Usana initiated  »

Usana initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FLY

Fly Leasing

$18.25

0.265 (1.47%)

07:02
08/22/19
08/22
07:02
08/22/19
07:02
Earnings
Fly Leasing reports Q2 adjusted EPS $1.92, consensus $1.43 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 03

    Sep

  • 05

    Sep

PTITF

Indosat

$0.00

(0.00%)

07:01
08/22/19
08/22
07:01
08/22/19
07:01
Downgrade
Indosat rating change  »

Indosat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCTY

Paylocity

$109.41

3.22 (3.03%)

07:01
08/22/19
08/22
07:01
08/22/19
07:01
Initiation
Paylocity initiated  »

Paylocity initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BERY

Berry Global

$39.94

0.57 (1.45%)

07:00
08/22/19
08/22
07:00
08/22/19
07:00
Initiation
Berry Global initiated  »

Berry Global reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$89.14

1.85 (2.12%)

06:59
08/22/19
08/22
06:59
08/22/19
06:59
Recommendations
Keysight Technologies analyst commentary  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TGT

Target

$103.11

17.54 (20.50%)

06:57
08/22/19
08/22
06:57
08/22/19
06:57
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

PAYC

Paycom

$251.93

4.93 (2.00%)

06:57
08/22/19
08/22
06:57
08/22/19
06:57
Initiation
Paycom initiated  »

Paycom initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$22.54

0.915 (4.23%)

06:55
08/22/19
08/22
06:55
08/22/19
06:55
Hot Stocks
Breaking Hot Stocks news story on BJ's Wholesale »

BJ's Wholesale up 6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 15

    Sep

  • 24

    Sep

SQ

Square

$65.43

1.05 (1.63%)

06:53
08/22/19
08/22
06:53
08/22/19
06:53
Recommendations
Square analyst commentary  »

Square weakness a good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 10

    Sep

  • 27

    Oct

  • 06

    Nov

CSOD

Cornerstone OnDemand

$51.34

0.32 (0.63%)

06:53
08/22/19
08/22
06:53
08/22/19
06:53
Initiation
Cornerstone OnDemand initiated  »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

CCC

Clarivate Analytics

$17.65

0.085 (0.48%)

, TRI

Thomson Reuters

$67.48

0.39 (0.58%)

06:52
08/22/19
08/22
06:52
08/22/19
06:52
Hot Stocks
Clarivate Analytics announces buyout of tax receivable agreement »

Clarivate Analytics (CCC)…

CCC

Clarivate Analytics

$17.65

0.085 (0.48%)

TRI

Thomson Reuters

$67.48

0.39 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDAY

Ceridian

$56.73

2.585 (4.77%)

06:50
08/22/19
08/22
06:50
08/22/19
06:50
Initiation
Ceridian initiated  »

Ceridian initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

CNMD

Conmed

$97.17

1.16 (1.21%)

06:50
08/22/19
08/22
06:50
08/22/19
06:50
Upgrade
Conmed rating change  »

Conmed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

06:50
08/22/19
08/22
06:50
08/22/19
06:50
General news
FX Update »

FX Update: EUR-USD more…

LYTS

LSI Industries

$3.76

-0.17 (-4.33%)

06:49
08/22/19
08/22
06:49
08/22/19
06:49
Earnings
LSI Industries reports Q4 EPS 3c with items, consensus (2c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 01

    Oct

BJ

BJ's Wholesale

$22.54

0.915 (4.23%)

06:48
08/22/19
08/22
06:48
08/22/19
06:48
Hot Stocks
BJ's Wholesale CEO says Q2 results 'in line with our expectations' »

"Second quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 15

    Sep

  • 24

    Sep

HSBC

HSBC

$36.27

0.1 (0.28%)

, AVVIY

Aviva

$0.00

(0.00%)

06:47
08/22/19
08/22
06:47
08/22/19
06:47
Periodicals
HSBC considering offer for Aviva's Asian assets, Bloomberg reports »

HSBC (HSBC) is…

HSBC

HSBC

$36.27

0.1 (0.28%)

AVVIY

Aviva

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

SQM

SQM

$25.40

-0.86 (-3.27%)

06:47
08/22/19
08/22
06:47
08/22/19
06:47
Downgrade
SQM rating change  »

SQM downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.